References:
[1] Wali Y, Kini V, Yassin MA. Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region. Hematology. 2020 Jan 1;25(1):55-62.
[2] Menapace LA, Thein SL. COVID-19 and sickle cell disease. Haematologica 2020;105:2501–4. https://doi.org/10.3324/haematol.2020.255398.
[3] de Sanctis V, Canatan D, Corrons JL, Karimi M, Daar S, Kattamis C, Soliman AT, Wali Y, Alkindi S, Huseynov V, Nasibova A. Preliminary Data on COVID-19 in patients with hemoglobinopathies: A multicentre ICET-A study. Mediterranean Journal of Hematology and Infectious Diseases. 2020;12(1).
[4] Beerkens F, John M, Puliafito B, Corbett V, Edwards C, Tremblay D. COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient. Am J Hematol 2020;95:E154–6. https://doi.org/10.1002/ajh.25809.
[5] Chakravorty S, Padmore-Payne G, Ike F, Tshibangu V, Graham C, Rees D, et al. COVID-19 in patients with sickle cell disease – A case series from a UK tertiary hospital. Haematologica 2020;105:2691–3. https://doi.org/10.3324/haematol.2020.254250.
[6] Balanchivadze N, Kudirka AA, Askar S, Almadhoun K, Kuriakose P, Fadel R, et al. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA. Hemoglobin 2020. https://doi.org/10.1080/03630269.2020.1797775.
[7] Okar L, Aldeeb M, Yassin MA. The role of red blood cell exchange in sickle cell disease in patient with COVID‐19 infection and pulmonary infiltrates. Clin Case Reports 2020:ccr3.3526. https://doi.org/10.1002/ccr3.3526.
[8] Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536–44. https://doi.org/10.1038/s41564-020-0695-z.
[9] AbdulRahman A, AlAli S, Yaghi O, Shabaan M, Otoom S, Atkin SL, et al. COVID-19 and sickle cell disease in Bahrain. Int J Infect Dis 2020;101:14–6. https://doi.org/10.1016/j.ijid.2020.09.1433.
[10] Yassin MA, Soliman AT, de Sanctis V, Abdula MA, Riaz LM, Ghori FF, Yousaf A, Nashwan AJ, Abusamaan S, Moustafa A, Kohla S. Statural growth and prevalence of endocrinopathies in relation to liver iron content (LIC) in adult patients with beta thalassemia major (BTM) and sickle cell disease (SCD). Acta Bio Medica: Atenei Parmensis. 2018;89(Suppl 2):33.
[11] Sivalingam T, Inusa B, Doyle P, Oteng‐Ntim E. COVID‐19 and the pulmonary complications of sickle cell disease. EJHaem 2020:545–7. https://doi.org/10.1002/jha2.105.
[12] Sheha D, El-Shayeb M, Eid Y, Amin M, Saeed A, Abdou D, et al. Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection. Br J Haematol 2020;191:e38–40. https://doi.org/10.1111/bjh.17089.
[13] London S, London S. Ase eports 2020;105:2691–3.
[14] Torti L, Maffei L, Sorrentino F, De Fabritiis P, Miceli R, Abruzzese E. Impact of SARS CoV-2 in hemoglobinopathies: a protective mechanism being from Beta chain Hemoglobin defects? Mediterr J Hematol Infect Dis 2020;12:e2020052. https://doi.org/10.4084/mjhid.2020.052.
[15] wenzhong liu, hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism 2020. https://doi.org/10.26434/CHEMRXIV.11938173.V7.